Compare · BYAH vs HLN
BYAH vs HLN
Side-by-side comparison of Park Ha Biological Technology Co. Ltd. (BYAH) and Haleon plc (HLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BYAH and HLN operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- HLN is the larger of the two at $44.53B, about 6328.7x BYAH ($7.0M).
- Over the past year, BYAH is down 98.6% and HLN is up 2.1% - HLN leads by 100.7 points.
- HLN has been more active in the news (18 items in the past 4 weeks vs 5 for BYAH).
- HLN has more recent analyst coverage (19 ratings vs 0 for BYAH).
- Company
- Park Ha Biological Technology Co. Ltd.
- Haleon plc
- Price
- $2.99+0.67%
- $10.01+1.42%
- Market cap
- $7.0M
- $44.53B
- 1M return
- -6.74%
- +3.04%
- 1Y return
- -98.60%
- +2.09%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- 2022
- News (4w)
- 5
- 18
- Recent ratings
- 0
- 19
Haleon plc
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.
Latest BYAH
- New insider Wang Li (Alya) claimed ownership of 187,500 units of Class A Ordinary Shares (SEC Form 3)
- CFO Zhu Xiaoyan was granted 112,500 units of Class A Ordinary Shares (SEC Form 4)
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form S-8 filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- Park Ha Biological Technology Co., Ltd. Announces Official Approval of Its North American Amazon Store, Launching a New Era of Brand Globalization
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
Latest HLN
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- Haleon plc: Announces Pricing Terms, Expiration and Results of its Cash Tender Offer for outstanding 2027 Notes
- SEC Form 6-K filed by Haleon plc
- Centrum Reframes Healthy Aging as a Proactive Practice for Adults 35 and Beyond
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes